The need to increase diversity in clinical trials


The time has come for organizers of clinical trials to recognize that in order for medications and devices to be maximally effective for all populations, a diverse mix of clinical trial participants is critical.

Previous Boston investment firms fielding lots of questions about struggling stock market
Next CommuniCare expands in West Virginia, Southeast Ohio with Stonerise acquisition